Jennifer Erker
Primary Care · Goddard, KSNPI 1528527439
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $828 and has fallen 85.0% since, to $125 in 2025.
Across 114 payments — averaging $13.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$251
- Lilly USA, LLC$240
- Pfizer$125
- Sanofi-aventis U.S. LLC$115
- Amgen$109
- AstraZeneca$101
- plus $577 from 17 others
What the payments were for
- Food & beverage$1,49398%
- Education$252%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $251 |
| Lilly USA, LLC | 18 | $240 |
| Pfizer | 11 | $125 |
| Sanofi-aventis U.S. LLC | 8 | $115 |
| Amgen | 7 | $109 |
| AstraZeneca | 7 | $101 |
| Neos Therapeutics, LP | 6 | $93 |
| Novo Nordisk | 6 | $84 |
| Currax Pharmaceuticals LLC | 4 | $65 |
| Johnson & Johnson | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $43 |
| Collegium Pharmaceutical, Inc. | 3 | $40 |
| Bayer | 2 | $37 |
| GSK | 2 | $24 |
| Dexcom, Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Merck | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$1,518 in reported general payments places this provider in the 80th percentile of 56 primary care providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 23 | $27,455 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 119 | $3,516 |
| Pregabalin | 12 | $1,477 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $774 |
| Gabapentin | 25 | $536 |
| Morphine Sulfate | 13 | $506 |
| Oxycodone Hcl | 11 | $491 |
| Potassium Chloride | 26 | $428 |
| Pantoprazole Sodium | 24 | $418 |
| Duloxetine Hcl | 16 | $363 |
| ValacyclovirValacyclovir Hcl | 13 | $352 |
| Morphine Sulfate ErMorphine Sulfate | 14 | $315 |
| ClopidogrelClopidogrel Bisulfate | 11 | $305 |
| Atorvastatin Calcium | 39 | $246 |
| Metformin Hcl | 20 | $165 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $240 | $27,45523 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 56 primary care providers in Kansas.
Other primary care in Goddard
- Michelle PragerTopeka$39K
- Kerry SanderStilwell$9K
- Kristina GroveOverland Park$9K
- Amy BakerLawrence$7K
- Thuy NguyenJetmore$4K
- Debra LyneSalina$4K
- Phuong DuongWichita$3K
- Danielle CarmitchelOverland Park$2K
- Erika DickChanute$2K
- Mayra BrooksConcordia$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.